Dideoxy Guanosine Triphosphate

Dideoxy Guanosine Triphosphate

SCHEMBL80109

Nc1nc2c(ncn2[C@H]2CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.60
▸ P2RY2 P41231 1/20 0.56
▸ P2RY4 P51582 1/20 0.56
▸ P2RY6 Q15077 1/20 0.56
▸ POLG P54098 2/20 0.55
▸ TGM2 P21980 1/20 0.55
▸ PNP P00491 3/20 0.54
▸ FUT5 Q11128 1/20 0.53
▸ KRAS P01116 2/20 0.52
▸ NT5E P21589 1/20 0.50
▸ POLA1 P09884 1/20 0.48
▸ HPRT1 P00492 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ ALB P02768 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ P2RX3 P56373 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dideoxy Guanosine Triphosphate SCHEMBL24370775 1.00 POLB (0.60) POLBP2RY2P2RY4P2RY6POLG
Dideoxy Guanosine Triphosphate SCHEMBL25720613 1.00 POLB (0.60) POLBP2RY2P2RY4P2RY6POLG
Dideoxy Guanosine Triphosphate SCHEMBL25712486 1.00 POLB (0.60) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL18095578 1.00 POLB (0.60) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL4968018 0.99 POLB (0.61) POLBP2RY2P2RY4P2RY6POLG
Dideoxy Guanosine Triphosphate SCHEMBL6915085 0.94 POLB (0.54) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL26855308 0.93 POLB (0.54) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL27378463 0.93 POLB (0.54) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL19662102 0.93 POLB (0.66) POLBP2RY2P2RY4P2RY6POLG
SCHEMBL1762945 0.92 POLB (0.57) POLBP2RY2P2RY4P2RY6POLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1944 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122095103-A Mutant DNA polymerase and methods of use thereof — 2026-05-26 — — CN claimed
US-12630865-B2 Products and processes for multiplex nucleic acid identification AGENA BIOSCIENCE, INC. (US) 2026-05-19 — — US claimed
EP-4724455-A1 MULTIVALENT BINDING UNIT MODIFIED DIDEOXYNUCLEOTIDE TRIPHOSPHATES AND METHODS OF MAKING AND USING THE SAME ILLUMINA, INC. (US) 2026-04-15 — — EP claimed
US-12597490-B2 Methods and systems for modeling phasing effects in sequencing using termination chemistry Life Technologies Corporation (US) 2026-04-07 — — US claimed
US-12480106-B2 Reactions with non-retroviral reverse transcriptase THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-25 — — US claimed
WO-2025235939-A1 METHODS FOR BALANCED AMPLIFICATION OF SMALL SAMPLES OF NUCLEIC ACIDS ORCHID BIOSCIENCE, INC. (US) 2025-11-13 — — WO claimed
US-12454722-B2 Multiplexed method for the identification and quantitation of minor alleles and polymorphisms AGENA BIOSCIENCE, INC. (US) 2025-10-28 — — US claimed
EP-4605547-A1 NOISE REDUCTION FOR DATA STORAGE IN DNA Catalog Technologies, Inc. (US) 2025-08-27 — — EP claimed
WO-2025105897-A1 METHOD FOR DETECTING GENOMIC MUTATION THROUGH NUCLEIC ACID PATTERN-BASED PURIFICATION, AND DISEASE DIAGNOSIS METHOD USING SAME 광주과학기술원 2025-05-22 — — WO claimed
US-20250154557-A1 COMPOSITION FOR SELECTING NUCLEIC ACIDS OF INTEREST, AND A METHOD FOR SELECTING NUCLEIC ACIDS USING THEREOF GWANGJU INST SCIENCE & TECH (KR) 2025-05-15 — — US claimed
US-5366860-A Spectrally resolvable rhodamine dyes for nucleic acid sequence determination APPLIED BIOSYSTEMS, INC. (US) 1994-11-22 — — US claimed
WO-1994016101-A2 DNA SEQUENCING BY MASS SPECTROMETRY KOESTER HUBERT (US) 1994-07-21 — — WO claimed
EP-0496749-A4 SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION — 1993-06-16 — — EP claimed
WO-1992022306-A1 TRANSFORMED ERYTHROCYTES, PROCESS FOR PREPARING THE SAME, AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS COMMUNAUTE ECONOMIQUE EUROPEENNE (CEE) (LU) 1992-12-23 — — WO claimed
EP-0496749-A1 SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION. APPLIED BIOSYSTEMS (US) 1992-08-05 — — EP claimed
EP-0286418-B1 ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEMS FOR THE SAME US COMMERCE (US) 1992-07-08 — — EP claimed
WO-1991005060-A2 SPECTRALLY RESOLVABLE RHODAMINE DYES FOR NUCLEIC ACID SEQUENCE DETERMINATION APPLIED BIOSYSTEMS, INC. (US) 1991-04-18 — — WO claimed
WO-1991005065-A1 AN IMPROVED METHOD OF DNA SEQUENCING STRATAGENE (US) 1991-04-18 — — WO claimed
WO-1988007854-A1 NEW ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEM UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) 1988-10-20 — — WO claimed
EP-0286418-A1 Anti-retroviral agents and delivery systems for the same THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1988-10-12 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630865-B2 Products and processes for multiplex nucleic acid identification POLM, POLN, POLL POLB 6/4885P2RY2 2279/4885P2RY4 1832/4885
US-12597490-B2 Methods and systems for modeling phasing effects in sequencing using termination chemistry RNGTT, TRHR, RIF1 POLB 13/4885P2RY2 1953/4885P2RY4 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback